The majority of autoimmune and allergic diseases are associated with abnormal expression of interleukin (IL)-33, a member of the IL-1 family of cytokines, that function dually as a proinflammatory cytokine and a transcriptional factor. Nội dung trích xuất từ tài liệu: Blockade of interleukin-33 activities by recombinant interleukin-33 trap FC protein would be a novel therapeutic strategy in allergic asthma